A receptor-mediated pathway for cholesterol homeostasis.
暂无分享,去创建一个
M. Brown | J. Goldstein | M. Brown | M. Brown
[1] D. Russell,et al. Exon-Alu recombination deletes 5 kilobases from the low density lipoprotein receptor gene, producing a null phenotype in familial hypercholesterolemia. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[2] D. Russell,et al. Deletion of clustered O-linked carbohydrates does not impair function of low density lipoprotein receptor in transfected fibroblasts. , 1986, The Journal of biological chemistry.
[3] Joseph L. Goldstein,et al. Internalization-defective LDL receptors produced by genes with nonsense and frameshift mutations that truncate the cytoplasmic domain , 1985, Cell.
[4] Russell F. Doolittle,et al. The genealogy of some recently evolved vertebrate proteins , 1985 .
[5] T. Südhof,et al. The LDL receptor gene: a mosaic of exons shared with different proteins. , 1985, Science.
[6] T. Südhof,et al. Cassette of eight exons shared by genes for LDL receptor and EGF precursor. , 1985, Science.
[7] J. Goldstein,et al. Membrane-bound domain of HMG CoA reductase is required for sterol-enhanced degradation of the enzyme , 1985, Cell.
[8] A. Endo,et al. Compactin (ML-236B) and related compounds as potential cholesterol-lowering agents that inhibit HMG-CoA reductase. , 1985, Journal of medicinal chemistry.
[9] J. Dietschy,et al. Rates of low density lipoprotein uptake and cholesterol synthesis are regulated independently in the liver. , 1985, Journal of lipid research.
[10] V. Schumaker,et al. Molecular weights of apoprotein B obtained from human low-density lipoprotein (apoprotein B-PI) and from rat very low density lipoprotein (apoprotein B-PIII). , 1985, Biochemistry.
[11] J. Luzio,et al. The sequence and topology of human complement component C9. , 1985, The EMBO journal.
[12] T. Südhof,et al. Mutation in LDL receptor: Alu-Alu recombination deletes exons encoding transmembrane and cytoplasmic domains. , 1985, Science.
[13] M. Brown,et al. The LDL receptor and HMG-CoA reductase--two membrane molecules that regulate cholesterol homeostasis. , 1985, Current topics in cellular regulation.
[14] D. Russell,et al. Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. , 1985, Annual review of cell biology.
[15] S. Grundy,et al. Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia. , 1984, The New England journal of medicine.
[16] M. Brown,et al. Progress in understanding the LDL receptor and HMG-CoA reductase, two membrane proteins that regulate the plasma cholesterol. , 1984, Journal of lipid research.
[17] M. Brown,et al. How LDL receptors influence cholesterol and atherosclerosis. , 1984, Scientific American.
[18] D R Illingworth,et al. Mevinolin plus colestipol in therapy for severe heterozygous familial hypercholesterolemia. , 1984, Annals of internal medicine.
[19] D. Russell,et al. The human LDL receptor: A cysteine-rich protein with multiple Alu sequences in its mRNA , 1984, Cell.
[20] C. E. Becker. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. , 1984, JAMA.
[21] R. Mahley,et al. Normalization of receptor binding of apolipoprotein E2. Evidence for modulation of the binding site conformation. , 1984, The Journal of biological chemistry.
[22] D. Russell,et al. Domain map of the LDL receptor: Sequence homology with the epidermal growth factor precursor , 1984, Cell.
[23] U. Francke,et al. Assignment of the human gene for the low density lipoprotein receptor to chromosome 19: synteny of a receptor, a ligand, and a genetic disease. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[24] S. Grundy,et al. Inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase by mevinolin in familial hypercholesterolemia heterozygotes: effects on cholesterol balance. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[25] W. Hazzard,et al. Down-regulation of the low-density lipoprotein receptor by dietary cholesterol. , 1984, The American journal of clinical nutrition.
[26] Russell F. Doolittle,et al. Computer-based characterization of epidermal growth factor precursor , 1984, Nature.
[27] S. Connor,et al. THE INTERACTION OF GENETIC AND NUTRITIONAL FACTORS IN HYPERLIPIDEMIA , 1984 .
[28] The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. , 1984, JAMA.
[29] R. Cummings,et al. Biosynthesis of N- and O-linked oligosaccharides of the low density lipoprotein receptor. , 1983, The Journal of biological chemistry.
[30] D. Russell,et al. cDNA cloning of the bovine low density lipoprotein receptor: feedback regulation of a receptor mRNA. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[31] J. D. Capra,et al. Use of antipeptide antibodies to demonstrate external orientation of the NH2-terminus of the low density lipoprotein receptor in the plasma membrane of fibroblasts , 1983, The Journal of cell biology.
[32] M. Brown,et al. Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic. , 1983, The Journal of clinical investigation.
[33] T. Kita,et al. Defective lipoprotein receptors and atherosclerosis. Lessons from an animal counterpart of familial hypercholesterolemia. , 1983, The New England journal of medicine.
[34] W. Rutter,et al. Structure of a mouse submaxillary messenger RNA encoding epidermal growth factor and seven related proteins. , 1983, Science.
[35] M. Brown,et al. Amplification of the gene for 3-hydroxy-3-methylglutaryl coenzyme A reductase, but not for the 53-kDa protein, in UT-1 cells. , 1983, The Journal of biological chemistry.
[36] I. Pastan,et al. Receptor-mediated endocytosis: coated pits, receptosomes and the Golgi , 1983 .
[37] D. Steinberg. Lipoproteins and atherosclerosis. A look back and a look ahead. , 1983, Arteriosclerosis.
[38] D. Bilheimer,et al. Rates of receptor-dependent and -independent low density lipoprotein uptake in the hamster. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[39] A. Ullrich,et al. Nucleotide sequence of epidermal growth factor cDNA predicts a 128,000-molecular weight protein precursor , 1983, Nature.
[40] R. Mahley,et al. Lipoprotein receptors and cholesterol homeostasis. , 1983, Biochimica et biophysica acta.
[41] H. Mabuchi,et al. Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine. , 1983, The New England journal of medicine.
[42] J. Goldstein,et al. The LDL receptor locus in familial hypercholesterolemia: Multiple mutations disrupt transport and processing of a membrane receptor , 1983, Cell.
[43] Joseph L. Goldstein,et al. Recycling receptors: The round-trip itinerary of migrant membrane proteins , 1983, Cell.
[44] A. Helenius,et al. Penetration of semliki forest virus from acidic prelysosomal vacuoles , 1983, Cell.
[45] S. Grundy,et al. Mevinolin stimulates receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes. , 1983, Transactions of the Association of American Physicians.
[46] C. de Duve. Lysosomes revisited. , 1983, European journal of biochemistry.
[47] F. Maxfield. Weak bases and ionophores rapidly and reversibly raise the pH of endocytic vesicles in cultured mouse fibroblasts , 1982, The Journal of cell biology.
[48] J. Goldstein,et al. Posttranslational processing of the LDL receptor and its genetic disruption in familial hypercholesterolemia , 1982, Cell.
[49] L. Orci,et al. Co-localization of 125I-epidermal growth factor and ferritin-low density lipoprotein in coated pits: a quantitative electron microscopic study in normal and mutant human fibroblasts , 1982, The Journal of cell biology.
[50] D. Bilheimer,et al. Delayed clearance of very low density and intermediate density lipoproteins with enhanced conversion to low density lipoprotein in WHHL rabbits. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[51] A. Attie,et al. Receptor-dependent and receptor-independent degradation of low density lipoprotein in normal rabbits and in receptor-deficient mutant rabbits. , 1982, The Journal of biological chemistry.
[52] A. Soutar,et al. The metabolism of very low density and intermediate density lipoproteins in patients with familial hypercholesterolaemia. , 1982, Atherosclerosis.
[53] R. Havel,et al. Hepatic uptake of chylomicron remnants in WHHL rabbits: a mechanism genetically distinct from the low density lipoprotein receptor. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[54] M. Brown,et al. Purification of the low density lipoprotein receptor, an acidic glycoprotein of 164,000 molecular weight. , 1982, The Journal of biological chemistry.
[55] G. Ashwell,et al. Carbohydrate-specific receptors of the liver. , 1982, Annual review of biochemistry.
[56] M. Brown,et al. Recycling of cell-surface receptors: observations from the LDL receptor system. , 1982, Cold Spring Harbor symposia on quantitative biology.
[57] I. Pastan,et al. Journey to the center of the cell: role of the receptosome. , 1981, Science.
[58] M. Brown,et al. Lowering plasma cholesterol by raising LDL receptors. , 1981, The New England journal of medicine.
[59] R. Mahley,et al. Lipoprotein binding to canine hepatic membranes. Metabolically distinct apo-E and apo-B,E receptors. , 1981, The Journal of biological chemistry.
[60] Richard G. W. Anderson,et al. Monensin interrupts the recycling of low density lipoprotein receptors in human fibroblasts , 1981, Cell.
[61] R. Deitch. Commentary from Westminster , 1981, The Lancet.
[62] M. Brown,et al. Saturation and suppression of hepatic lipoprotein receptors: a mechanism for the hypercholesterolemia of cholesterol-fed rabbits. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[63] D. Bilheimer,et al. Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[64] M. Brown,et al. Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase. , 1980, The Journal of clinical investigation.
[65] D. J. Howard,et al. Functional segregation of hepatic receptors for asialoglycoproteins during endocytosis. , 1980, The Journal of biological chemistry.
[66] R Monaghan,et al. Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[67] Y. Watanabe. Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit). , 1980, Atherosclerosis.
[68] C. Oakley,et al. Assessment of long-term plasma exchange for familial hypercholesterolaemia. , 1980, British heart journal.
[69] J. Grubb,et al. Chloroquine inhibits lysosomal enzyme pinocytosis and enhances lysosomal enzyme secretion by impairing receptor recycling , 1980, The Journal of cell biology.
[70] A. Endo,et al. Therapeutic effects of ML-236B in primary hypercholesterolemia. , 1980, Atherosclerosis.
[71] A. Helenius,et al. On the entry of semliki forest virus into BHK-21 cells , 1980, The Journal of cell biology.
[72] A. Keys,et al. Seven countries. A multivariate analysis of death and coronary heart disease. , 1980 .
[73] Yoshio Watanabe,et al. Incidence and Development of Atherosclerosis and Xanthoma , 1980 .
[74] Y. Chao,et al. Hepatic catabolism of rat and human lipoproteins in rats treated with 17 alpha-ethinyl estradiol. , 1979, The Journal of biological chemistry.
[75] M. Brown,et al. Increased binding of low density lipoprotein to liver membranes from rats treated with 17 alpha-ethinyl estradiol. , 1979, The Journal of biological chemistry.
[76] C. Packard,et al. Receptor-mediated low density lipoprotein catabolism in man. , 1979, Journal of lipid research.
[77] S. Grundy,et al. Metabolic studies in familial hypercholesterolemia. Evidence for a gene-dosage effect in vivo. , 1979, The Journal of clinical investigation.
[78] M. Brown,et al. Receptor-mediated endocytosis: insights from the lipoprotein receptor system. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[79] Joseph L. Goldstein,et al. Coated pits, coated vesicles, and receptor-mediated endocytosis , 1979, Nature.
[80] M. Brown,et al. Low density lipoprotein receptors in bovine adrenal cortex. II. Low density lipoprotein binding to membranes prepared from fresh tissue. , 1979, Endocrinology.
[81] M. Brown,et al. Receptor-mediated uptake of lipoprotein-cholesterol and its utilization for steroid synthesis in the adrenal cortex. , 1979, Recent progress in hormone research.
[82] R. Mahley,et al. Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts. , 1978, The Journal of biological chemistry.
[83] M. Brown,et al. Characterization of the low density lipoprotein receptor in membranes prepared from human fibroblasts. , 1978, The Journal of biological chemistry.
[84] R. Mahley,et al. Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins. , 1978, Biochemistry.
[85] J. Dietschy,et al. Characterization of the sinusoidal transport process responsible for uptake of chylomicrons by the liver. , 1978, The Journal of biological chemistry.
[86] K.,et al. Genetics of the low density lipoprotein receptor. Diminished receptor activity in lymphocytes from heterozygotes with familial hypercholesterolemia. , 1978, The Journal of clinical investigation.
[87] W. Gilbert. Why genes in pieces? , 1978, Nature.
[88] M. Brown,et al. Biologically active low density lipoprotein in human peripheral lymph. , 1978, The Journal of clinical investigation.
[89] Richard G. W. Anderson,et al. A mutation that impairs the ability of lipoprotein receptors to localise in coated pits on the cell surface of human fibroblasts , 1977, Nature.
[90] M. Brown,et al. Atherosclerosis: the low-density lipoprotein receptor hypothesis. , 1977, Metabolism: clinical and experimental.
[91] N. Stone,et al. Genetics of the LDL receptor: Evidence that the mutations affecting binding and internalization are allelic , 1977, Cell.
[92] R. Mahley,et al. Inhibition of lipoprotein binding to cell surface receptors of fibroblasts following selective modification of arginyl residues in arginine-rich and B apoproteins. , 1977, The Journal of biological chemistry.
[93] Richard G. W. Anderson,et al. Role of the coated endocytic vesicle in the uptake of receptor-bound low density lipoprotein in human fibroblasts , 1977, Cell.
[94] G. Shipley,et al. Structure and interactions of lipids in human plasma low density lipoproteins. , 1977, The Journal of biological chemistry.
[95] M. Brown,et al. The low-density lipoprotein pathway and its relation to atherosclerosis. , 1977, Annual review of biochemistry.
[96] A. Garvin,et al. The transport of lysosomal enzymes. , 1977, Journal of supramolecular structure.
[97] M. Kuroda,et al. Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity. , 2004, FEBS letters.
[98] J. Goldstein,et al. Analysis of a mutant strain of human fibroblasts with a defect in the internalization of receptor-bound low density lipoprotein , 1976, Cell.
[99] D. Bilheimer,et al. Regulation of low density lipoprotein receptor activity in freshly isolated human lymphocytes. , 1976, The Journal of clinical investigation.
[100] G. Carpenter,et al. 125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts , 1976, The Journal of cell biology.
[101] M. Brown,et al. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[102] M. Brown,et al. Localization of low density lipoprotein receptors on plasma membrane of normal human fibroblasts and their absence in cells from a familial hypercholesterolemia homozygote. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[103] R. Mahley,et al. Interaction of swine lipoproteins with the low density lipoprotein receptor in human fibroblasts. , 1976, The Journal of biological chemistry.
[104] B. Pearse,et al. Clathrin: a unique protein associated with intracellular transfer of membrane by coated vesicles. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[105] J. Goldstein,et al. Release of low density lipoprotein from its cell surface receptor by sulfated glycosaminoglycans , 1976, Cell.
[106] G. Calvert. Mammalian Low Density Lipoproteins , 1976 .
[107] S. Grundy,et al. Reduction in cholesterol and low density lipoprotein synthesis after portacaval shunt surgery in a patient with homozygous familial hypercholesterolemia. , 1975, The Journal of clinical investigation.
[108] D. Steiner,et al. Binding and degradation of 125I-insulin by rat hepatocytes. , 1975, The Journal of biological chemistry.
[109] A. Beaudet,et al. Role of lysosomal acid lipase in the metabolism of plasma low density lipoprotein. Observations in cultured fibroblasts from a patient with cholesteryl ester storage disease. , 1975, The Journal of biological chemistry.
[110] J. Goldstein,et al. Regulation of the activity of the low density lipoprotein receptor in human fibroblasts , 1975, Cell.
[111] M. Brown,et al. Inhibition of proteolytic degradation of low density lipoprotein in human fibroblasts by chloroquine, concanavalin A, and Triton WR 1339. , 1975, The Journal of biological chemistry.
[112] L. Simons,et al. The metabolism of the apoprotein of plasma low density lipoprotein in familial hyperbetalipoproteinaemia in the homozygous form. , 1975, Atherosclerosis.
[113] M. Brown,et al. Familial hypercholesterolemia: defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity. , 2009, Proceedings of the National Academy of Sciences of the United States of America.
[114] M. Brown,et al. Esterification of low density lipoprotein cholesterol in human fibroblasts and its absence in homozygous familial hypercholesterolemia. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[115] P. Tulkens,et al. Commentary. Lysosomotropic agents. , 1974, Biochemical pharmacology.
[116] M. Brown,et al. Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. , 1974, The Journal of biological chemistry.
[117] Joseph L. Goldstein,et al. Familial hypercholesterolemia: Defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme a reductase activity , 1974, Proceedings of the National Academy of Sciences.
[118] M. Brown,et al. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. , 1974, The Journal of biological chemistry.
[119] D. Fredrickson. Plasma lipoproteins and apolipoproteins. , 1974, Harvey lectures.
[120] M. Brown,et al. Familial hypercholesterolemia: identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity associated with overproduction of cholesterol. , 1973, Proceedings of the National Academy of Sciences of the United States of America.
[121] M. Brown,et al. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts by lipoproteins. , 1973, Proceedings of the National Academy of Sciences of the United States of America.
[122] A. Motulsky,et al. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. , 1973, The Journal of clinical investigation.
[123] A. Aro,et al. Family study of serum lipids and lipoproteins in coronary heart-disease. , 1973, Lancet.
[124] R. Levy,et al. Neonatal diagnosis of familial type-II hyperlipoproteinaemia. , 1973, Lancet.
[125] E. Sutherland,et al. Studies on the mechanism of hormone action. , 1972, Science.
[126] R. Levy,et al. The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia. , 1972, The Journal of clinical investigation.
[127] D. Bilheimer,et al. The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. , 1972, Biochimica et biophysica acta.
[128] D. Patterson,et al. Lipid abnormalities in male and female survivors of myocardial infarction and their first-degree relatives. , 1972, Lancet.
[129] W. Kannel,et al. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. , 2020, Annals of internal medicine.
[130] G. Mills,et al. The distribution and composition of serum lipoproteins in eighteen animals. , 1971, Comparative biochemistry and physiology. B, Comparative biochemistry.
[131] E. Neufeld,et al. Inborn errors of mucopolysaccharide metabolism. , 1970, Science.
[132] J. Dietschy,et al. Regulation of cholesterol metabolism. I. , 1970, The New England journal of medicine.
[133] Marvin D. Siperstein,et al. Regulation of cholesterol biosynthesis in normal and malignant tissues. , 1970 .
[134] J. D. Wilson,et al. Regulation of cholesterol metabolism. 3. , 1970, The New England journal of medicine.
[135] G. Rothblat,et al. Lipid metabolism in tissue culture cells. , 1967, Advances in lipid research.
[136] N. Myant. The regulation of cholesterol metabolism. , 1968, Postgraduate medical journal.
[137] Raymond Scalettar,et al. The Metabolic Basis of Inherited Disease , 1967 .
[138] A. Khachadurian. THE INHERITANCE OF ESSENTIAL FAMILIAL HYPERCHOLESTEROLEMIA. , 1964, The American journal of medicine.
[139] K. Porter,et al. YOLK PROTEIN UPTAKE IN THE OOCYTE OF THE MOSQUITO AEDES AEGYPTI. L , 1964, The Journal of cell biology.
[140] N. Bucher,et al. β-hydroxy-β-methylglutaryl coenzyme a reductase, cleavage and condensing enzymes in relation to cholesterol formation in rat liver , 1960 .
[141] N. Bucher,et al. beta-Hydroxy-beta-methyl-glutaryl coenzyme A reductase, cleavage and condensing enzymes in relation to cholesterol formation in rat liver. , 1960, Biochimica et biophysica acta.
[142] G. Beadle. Genes and Chemical Reactions in Neurospora: The concepts of biochemical genetics began with Garrod's "inborn errors" and have evolved gradually , 1959 .
[143] N. Bucher,et al. Cholesterol biosynthesis in preparations of liver from normal, fasting, x-irradiated, cholesterol-fed, triton, or delta 4-cholesten-3-one-treated rats. , 1959, The Journal of biological chemistry.
[144] E. Tatum. A case history in biological research. , 1958, Science.
[145] G. Beadle. Genes and chemical reactions in Neurospora. , 1959, Science.
[146] C. Janeway,et al. Studies on the metabolism of plasma proteins in the nephrotic syndrome. II. The lipoproteins. , 1958, The Journal of clinical investigation.
[147] V. Ingram,et al. Gene Mutations in Human Hæmoglobin: the Chemical Difference Between Normal and Sickle Cell Hæmoglobin , 1957, Nature.
[148] Oncley Jl. Lipoproteins of human plasma. , 1954 .
[149] J. Oncley. Lipoproteins of human plasma. , 1954, Harvey lectures.
[150] K. Bloch. Biological synthesis of cholesterol. , 1965, Harvey lectures.
[151] L. Pauling,et al. Sickle cell anemia a molecular disease. , 1949, Science.